063160 — CKD Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for CKD Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3,535	12,724	3,700	1,164	1,497
Net Total Accounts Receivable
Net Total Receivables	29,907	27,471	34,108	31,259	34,805
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	104,342	123,464	111,769	115,212	136,237
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	191,153	181,509	172,509	159,161	155,675
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	298,540	312,591	293,785	284,492	299,867
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	44,311	81,591	98,618	90,681	152,042
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	137,049	164,792	170,761	153,483	172,831
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	161,491	147,799	123,024	131,009	127,036
Total Liabilities & Shareholders' Equity	298,540	312,591	293,785	284,492	299,867
Total Common Shares Outstanding